西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2015年
4期
99-102
,共4页
2型糖尿病%红灵五黄汤%胰岛素抵抗%血糖%血酶%血脂
2型糖尿病%紅靈五黃湯%胰島素牴抗%血糖%血酶%血脂
2형당뇨병%홍령오황탕%이도소저항%혈당%혈매%혈지
type 2 diabetes mellitus%HongLing Wu Huang Tang%insulin resistance%blood glucose%blood enzymes%blood lipids
目的:观察红灵五黄汤治疗2型糖尿病(T2DM)的临床效果。方法:将180例患者随机分为治疗组和对照组各90例,治疗组给予红灵五黄汤治疗,对照组给予格列喹酮片和二甲双胍联合治疗,2组均以2个月为1个疗程,1个疗程后,观察症状、体征变化,检测空腹血糖(FBG)、餐后2小时血糖(2 hPG)、糖化血红蛋白(HbA1C)、肿瘤坏死因子α(TNF-α)、胰岛素抵抗(IR)、血酶及血脂的变化情况。结果:总有效率治疗组为88.8%,对照组为77.7%,治疗组优于对照组(P<0.05)。FBG、2 hPG、HbA1C、TNF-α、IR、血酶及血脂等指标2组治疗后与治疗前相比差异有统计学意义(P<0.05)。结论:红灵五黄汤治疗T2DM疗效显著,可能是通过健康胰岛B细胞,改善胰岛素抵抗,纠正血清酶的异常变化及降血糖、调血脂等过程而发挥作用的。
目的:觀察紅靈五黃湯治療2型糖尿病(T2DM)的臨床效果。方法:將180例患者隨機分為治療組和對照組各90例,治療組給予紅靈五黃湯治療,對照組給予格列喹酮片和二甲雙胍聯閤治療,2組均以2箇月為1箇療程,1箇療程後,觀察癥狀、體徵變化,檢測空腹血糖(FBG)、餐後2小時血糖(2 hPG)、糖化血紅蛋白(HbA1C)、腫瘤壞死因子α(TNF-α)、胰島素牴抗(IR)、血酶及血脂的變化情況。結果:總有效率治療組為88.8%,對照組為77.7%,治療組優于對照組(P<0.05)。FBG、2 hPG、HbA1C、TNF-α、IR、血酶及血脂等指標2組治療後與治療前相比差異有統計學意義(P<0.05)。結論:紅靈五黃湯治療T2DM療效顯著,可能是通過健康胰島B細胞,改善胰島素牴抗,糾正血清酶的異常變化及降血糖、調血脂等過程而髮揮作用的。
목적:관찰홍령오황탕치료2형당뇨병(T2DM)적림상효과。방법:장180례환자수궤분위치료조화대조조각90례,치료조급여홍령오황탕치료,대조조급여격렬규동편화이갑쌍고연합치료,2조균이2개월위1개료정,1개료정후,관찰증상、체정변화,검측공복혈당(FBG)、찬후2소시혈당(2 hPG)、당화혈홍단백(HbA1C)、종류배사인자α(TNF-α)、이도소저항(IR)、혈매급혈지적변화정황。결과:총유효솔치료조위88.8%,대조조위77.7%,치료조우우대조조(P<0.05)。FBG、2 hPG、HbA1C、TNF-α、IR、혈매급혈지등지표2조치료후여치료전상비차이유통계학의의(P<0.05)。결론:홍령오황탕치료T2DM료효현저,가능시통과건강이도B세포,개선이도소저항,규정혈청매적이상변화급강혈당、조혈지등과정이발휘작용적。
To observe clinical efficacy ofHongLingWuHuangTangin the treatment of type 2 dia-betes mellitus (T2DM). Methods: Totally180 patients with T2DM were randomly allocated to the treatment group and the control group, with 90 cases in each. HongLingWuHuang Tang was used in the treatment group. The combi-nation therapy of gliquidone tablets and metformin was carried out in the control group. Two months were one course of the treatment for both groups. After a course of treatment, the changes in symptoms and signs were ob-served, fasting blood glucose (FBG), 2 h postprandial glucose (2 hPG), glycosylated hemoglobin (HbA1C), tumor necrosis factor-α(TNF-α), insulin resistance (IR), blood enzymes and blood lipids detected. Results: Total effective rate in the treatment group was 88.8%, which was superior than 77.7% in the control group (P<0.05). The differ-ences in FBG, 2 hPG, HbA1C, TNF-α, IR, blood enzymes and blood lipids of two groups were statistically signifi-cant before and after the treatment (P<0.05). Conclusion: Clinical efficacy ofHongLingWuHuangTangis signifi-cant on T2DM. The possible mechanism rests on invigorating pancreatic B cells, improving IR, correcting abnormal serum enzymes, lowering blood glucose and transferring blood lipids.